top of page
AI pixabay huge.jpg

Payors Need Robust Review Processes to Prepare for Wave of Digital Therapeutics

Digital therapeutics are gaining momentum. As such, payors need to keep an eye on product approvals and pending legislation, and develop a robust process for how such products will be considered for their formularies and covered, speakers said during AMCP 2023.







Comentários


bottom of page